How we are transforming

A partnership approach

Global Innovation Director, Mattia De Dominicis, explains how collaboration is driving our development of potentially less harmful products.

"For us, creating a healthier future is a team effort. Our partners are embedded at every stage of the innovation cycle."

Read the full story from Mattia

A challenger business

Kim Reed, President and CEO of our US business, explains how we embrace our smaller size to drive growth in our largest market.

"We have the advantage of staying relatively nimble, able to respond quickly to changing consumer demands and preferences."

Read the full story from Kim

Our focused strategy

We focus our investment and resources around our five most important markets of USA, Germany, UK, Australia and Spain, which represent more than 70 per cent of our operating profit.

We are rolling out potentially reduced harm products in markets where there is proven consumer demand and where we believe we can make an impact.

We see additional opportunities to drive future growth while realising efficiencies in how we operate

Powered by responsibility

The communities among whom we work and live rightly expect us to act with the highest integrity and to work tirelessly to improve our social and environment impact.

Healthier Futures

Challenger histories

Our unique heritage is formed from the histories of the diverse businesses that came to together to form Imperial. What unites them all is their track record of innovation and challenging for consumers.

A diverse leadership team

Imperial’s Board and senior management combines broad consumer experience with deep knowledge of the tobacco sector.

Meet our leadership team